PYROSTAR™ Neo+ uses genetic engineering technology to generate reactive components for detecting endotoxins in pharmaceutical manufacturing and medical device production facilities.
Offering enhanced negative control stability and improved endotoxin recovery when testing heparin and heparin-derived products, Neo+ delivers equivalent endotoxin detection sensitivity to conventional limulus amebocyte lysate (LAL) testing, while employing a more sustainable and eco-conscious methodology.
The PYROSTAR™ Neo+ delivers precise and targeted endotoxin detection capabilities.
Features
- Compatible with standard plate readers for colorimetric measurement
- Employs a 3-factor mechanism that replicates traditional LAL cascade reactions
- Specifically targets endotoxins, preventing false positives from (1-->3)ß-D-Glucan interference
- Completely eliminates horseshoe crab blood usage
- The detection range spans from 0.001 to 50 EU/mL
- Delivers consistent results with minimal batch variation
- Maintains stability post-reconstitution (4 hrs. at 2-8°C and 2 weeks at -30°C)
- Comprehensive validation documentation provided by the manufacturer
For comparison of recombinant endotoxin testing using rFC with traditional LAL based reagents and how to implement the change, read expert insights on Sustainable and Compendial Endotoxin Testing with Recombinant PYROSTAR™ Neo+
For additional details, visit FUJIFILM Wako or click the Request Information button below to reach the supplier.
